• Nenhum resultado encontrado

Triple negative breast cancer

A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.

A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.

... the Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) were retrospectively collected for this ...cases. Triple- negative breast cancer was defined as estrogen ...

10

There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population.

There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population.

... Triple-negative breast cancer (TNBC) is defined by the lack of the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 ...

8

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment

How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment

... Triple negative breast cancer (TNBC) is a type of breast cancer (BC) that does not express the oestrogen and the progesterone receptors and the human epidermal growth factor ...

11

Androgen receptor expression in triple-negative breast cancer

Androgen receptor expression in triple-negative breast cancer

... in breast carcinomas especially in metaplastic carcinoma, which although less frequent, is inserted into the differentiation pathway of progenitor/myoepithelial cells of the mammary carcinogenesis [59] ...

80

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer

... 2010). Triple-negative breast cancer (TNBC) is a subtype characterized by the lack of ER, PR, and HER2 expression and is associated with younger age at diagnosis (Dent et ...all breast ...

5

Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.

Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.

... for triple-negative breast cancer (TNBC) are limited; intermediate-conductance calcium-activated potassium (SK4) channels are closely involved in tumor progression, but little is known about ...

17

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.

... in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast ...in ...

7

Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.

Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.

... Triple-Negative Breast Cancer (TNBC) is clinically defined by the lack of expression of the estrogen (ER) and progesterone (PgR) receptor genes, and by the absence of amplification of human ...

12

The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.

The differences in ultrasound and clinicopathological features between basal-like and normal-like subtypes of triple negative breast cancer.

... Breast ultrasound examinations were performed by the particular sonographer with 3 years of experience and were interpreted by two sonographers, each with 5 years of experience in the di- agnosis of breast ...

13

A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.

A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.

... in breast carcinomas, but the correlation between Ki-67 expression and chemosensitivity in the triple- negative phenotype is not clear[10], probably due to heterogeneous characteristics of ...

7

HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.

HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.

... in breast cancer specimens compared to adjacent normal mammary glands correlating significantly with lymphatic vessel invasion and survival rate ...in cancer cells [23, ...

20

Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.

Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype.

... lung cancer, esophageal squamous cell carcinoma, hepatocellular carcinoma, Wilm’s tumor and multiple myeloma ...of breast cancer patients, in particular hormone-resistant patients ...in triple ...

7

Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.

Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.

... consecutive breast cancer patients described previously [15] we studied a group of 165 consecutive women with TNBC unselected for family history and a group of 46 consecutive patients with ...

14

Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?

Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?

... patients negative for HR, the 10-year LRR rate was ...pT1–2N0-1M0 breast cancer who are at high risk for ...and triple nega- tive subtypes ...for triple negative breast ...

11

Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer

Hormone receptor-negative as a predictive factor for pathologic complete response to neoadjuvant therapy in breast cancer

... P, Blohmer JU, Tesch H, Khandan F, Jud S, Jackisch C, Mehta K, Loibl S, Untch M; German Breast Group. A randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple ...

7

J. Bras. Patol. Med. Lab.  vol.51 número6

J. Bras. Patol. Med. Lab. vol.51 número6

... Introduction: Breast cancer is the most common visceral malignancy in women, the leading cause of cancer death among women ...The triple negative subgroup has poor prognosis and ...

10

Perfil molecular do câncer de mama triplo negativo: Uma revisão sistemática / Molecular profile of negative triple breast cancer: A systematic review

Perfil molecular do câncer de mama triplo negativo: Uma revisão sistemática / Molecular profile of negative triple breast cancer: A systematic review

... Breast cancer is a disease of worldwide relevance because it is the first cause of cancer and the first cause of cancer mortality in women in Brazil and in the ...the triple ...

21

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

... of breast cancer and were mainly associated with ER status and proliferation ...of breast cancer stem cells after chemother- apy [51] which can be blocked with IL-8 directed drugs ...

11

An update on breast cancer multigene prognostic tests-emergent clinical biomarkers

An update on breast cancer multigene prognostic tests-emergent clinical biomarkers

... of breast cancer by DNA microarray analysis has revealed crucial classification systems by gene expression profile ...of breast carcinomas were identified: ER-positive/HER2-negative (luminal A ...

12

Rev. Bras. Ginecol. Obstet.  vol.37 número7

Rev. Bras. Ginecol. Obstet. vol.37 número7

... early-stage breast cancer by IHC may aid predictions of axillary lymph node me- ...a triple-negative subtype is predictive of a lower incidence of axillary lymph node ...for breast ...

6

Show all 7353 documents...

temas relacionados